Advertisement
Advertisement
CODX
Co-Diagnostics, Inc. Common Stock
1.97
USDSponsored
-0.22
-9.69%
Mar 25, 16:00 UTC -4
Closed
Pre-Market
1.98
+0.01
+0.30%
CODX Earnings Reports
Positive Surprise Ratio
CODX beat 15 of 28 last estimates.
54%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$166.77K
/-$3.82
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
+231.68%
/-46.94%
Co-Diagnostics, Inc. Common Stock earnings per share and revenue
On Mar 19, 2026, CODX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -3.67 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 128.52 thousand, with a --% difference. The market reacted with a -2.26% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -3.82 USD, with revenue projected to reach 166.77 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
FAQ
What were Co-Diagnostics, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Co-Diagnostics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Co-Diagnostics, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -2.26%, changed from $2.65 before the earnings release to $2.59 the day after.
When is Co-Diagnostics, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Co-Diagnostics, Inc. Common Stock's next earnings report?
Based on 4
analysts, Co-Diagnostics, Inc. Common Stock is expected to report EPS of -$3.82 and revenue of $166.77K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement